CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats

References

• KannarkatGLasherEESchiffDNeurologic complications of chemotherapy agentsCurr Opin Neurol200720671972517992096
   PubMed Web of Science ®Google Scholar
• KuroiKShimozumaKNeurotoxicity of taxanes: symptoms and quality of life assessmentBreast Cancer2004111929914718800
   PubMedGoogle Scholar
• WindebankAJGrisoldWChemotherapy-induced neuropathyJ Peripher Nerv Syst2008131274618346229
   PubMed Web of Science ®Google Scholar
• CataJPWengHRLeeBNReubenJMDoughertyPMClinical and experimental finding in humans and animals with chemotherapy-induced peripheral neuropathyMinerva Anestesiol200672315116916493391
   PubMed Web of Science ®Google Scholar
• BennettGJNeuropathic painWallPDMelzackRTextbook of Pain3rd edLondonChurchill Livingston1994201220
   Google Scholar
• CampbellJNMeyerRAMechanisms of neuropathic painNeuron2006521779217015228
   PubMed Web of Science ®Google Scholar
• AdamsJPalombellaVJSausvilleEAProteasome inhibitors: a novel class of potent and effective antitumor agentsCancer Res199959112615262210363983
   PubMed Web of Science ®Google Scholar
• CurranMPMcKeageKBortezomib: a review of its use in patients with multiple myelomaDrugs200969785988819441872
   PubMed Web of Science ®Google Scholar
• TobinaiKProteasome inhibitor, bortezomib, for myeloma and lymphomaInt J Clin Oncol200712531832617929113
   PubMed Web of Science ®Google Scholar
• KennedyBGargoumFBystrickyBCurranDRO’ConnorTMNovel agents in the management of lung cancerCurr Med Chem201017354291432520939812
   PubMed Web of Science ®Google Scholar
• HideshimaTChauhanDRichardsonPNF-kappa B as a therapeutic target in multiple myelomaJ Biol Chem200227719166391664711872748
   PubMed Web of Science ®Google Scholar
• LenzHJClinical update: proteasome inhibitors in solid tumorsCancer Treat Rev200329Suppl 1S41S48
   Web of Science ®Google Scholar
• CavalettiGNobile-OrazioEBortezomib-induced peripheral neurotoxicity: still far from a painless gainHaematologica200792101308131018024368
   PubMed Web of Science ®Google Scholar
• PariniAMoudanosCGPizzinatNLanierSMThe elusive family of imidazoline binding sitesTrends Pharmacol Sci199617113168789353
   PubMed Web of Science ®Google Scholar
• FinnDPMartíOHarbuzMSBehavioral, neuroendocrine and neurochemical effects of the imidazoline I2 receptor selective ligand BU224 in naive rats and rats exposed to the stress of the forced swim testPsychopharmacology (Berl)2003167219520212652345
   PubMed Web of Science ®Google Scholar
• HeadGAMayorovDNImidazoline receptors, novel agents and therapeutic potentialCardiovasc Hematol Agents Med Chem200641173216529547
   PubMedGoogle Scholar
• LioneLANuttDJHudsonALCharacterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I2 receptorsEur J Pharmacol199835311231359721049
   PubMed Web of Science ®Google Scholar
• LiJXZhangYImidazoline I2 receptors: target for new analgesics?Eur J Pharmacol20116582–3495621371460
   PubMed Web of Science ®Google Scholar
• EglenRMHudsonALKendallDA‘Seeing through a glass darkly’: casting light on imidazoline ‘I’ sitesTrends Pharmacol Sci19981993813909786027
   PubMed Web of Science ®Google Scholar
• MattiaCColuzziFIndantadol, a novel NMDA antagonist and nonselective MAO inhibitor for the potential treatment of neuropathic painIDrugs200710963664417786847
   PubMed Web of Science ®Google Scholar
• DinaOAKhasarSGAlessandri-HaberNNeurotoxic catecholamine metabolite in nociceptors contributes to painful peripheral neuropathyEur J Neurosci200928611801190 partial retraction in Eur J Neurosci2009;30(11):2235.18783367
   PubMed Web of Science ®Google Scholar
• FerrariFFiorentinoSMennuniLAnalgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic painJ Pain Res2011411112521647215
   PubMedGoogle Scholar
• HwangSLLiuIMTzengTFChengJTActivation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozotocin-induced diabetic ratsDiabetologia200548476777515756537
   PubMed Web of Science ®Google Scholar
• ChangCHWuHTChengKCLinHJChengJTIncrease of beta-endorphin secretion by agmatine is induced by activation of imidazoline I(2A) receptors in adrenal gland of ratsNeurosci Lett2010468329729919913596
   PubMed Web of Science ®Google Scholar
• CavalettiGGilardiniACantaABortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the ratExp Neurol2007204131732517214983
   PubMed Web of Science ®Google Scholar
• CantaAChiorazziAMeregalliCContinuous buprenorphine delivery effect in streptozotocine-induced painful diabetic neuropathy in ratsJ Pain200910996196819595641
   PubMed Web of Science ®Google Scholar
• MeregalliCCantaACarozziVABortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in ratsEur J Pain201014434335019695912
   PubMed Web of Science ®Google Scholar
• CantaAChiorazziACarozziVIn vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (Lipoplatin™)Cancer Chemother Pharmacol20116841001100821327681
   PubMed Web of Science ®Google Scholar
• CavalettiGCavallettiEMontagutiPOggioniNDe NegriOTrediciGEffect on the peripheral nervous system of the short-term intravenous administration of paclitaxel in the ratNeurotoxicology19971811371459215996
   PubMed Web of Science ®Google Scholar
• CavalettiGFabbricaDMinoiaCFrattolaLTrediciGCarboplatin toxic effects on the peripheral nervous system of the ratAnn Oncol1998944434479636837
   PubMed Web of Science ®Google Scholar
• MottaEMCalixtoJBRaeGAMechanical hyperalgesia induced by endothelin-1 in rats is mediated via phospholipase C, protein kinase C, and MAP kinasesExp Biol Med (Maywood)200623161141114516741065
   PubMed Web of Science ®Google Scholar
• CavalettiGTrediciGMarmiroliPPetruccioliMGBarajonIFabbricaDMorphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in ratsActa Neuropathol19928443643711441917
   PubMed Web of Science ®Google Scholar
• PersohnECantaASchoepferSMorphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in ratsEur J Cancer200541101460146615913989
   PubMed Web of Science ®Google Scholar
• MoreauPPylypenkoHGrosickiSSubcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority studyLancet Oncol201112543144021507715
   PubMed Web of Science ®Google Scholar
• KortümMEinseleHResults of the first bortezomib-based induction therapy in the treatment of multiple myelomaExpert Opin Pharmacother201112101661166321554151
   PubMed Web of Science ®Google Scholar
• ArgyriouAAIconomouGKalofonosHPBortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literatureBlood200811251593159918574024
   PubMed Web of Science ®Google Scholar
• MohtyBEl-CheikhJYakoub-AghaIMoreauPHarousseauJLMohtyMPeripheral neuropathy and new treatments for multiple myeloma: background and practical recommendationsHaematologica201095231131920139393
   PubMed Web of Science ®Google Scholar
• ObataHSaitoSKoizukaSNishikawaKGotoFThe monoamine-mediated antiallodynic effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a rat model of neuropathic painAnesth Analg200510051406141015845695
   PubMed Web of Science ®Google Scholar
• SawynokJEsserMJReidARPeripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the ratPain199982214915810467920
   PubMed Web of Science ®Google Scholar
• McQuayHJTramèrMNyeBACarrollDWiffenPJMooreRAA systematic review of antidepressants in neuropathic painPain1996682–32172279121808
   PubMed Web of Science ®Google Scholar
• MoulinDEClarkAJGilronIPharmacological management of chronic neuropathic pain: consensus statement and guidelines from the Canadian Pain SocietyPain Res Manag2007121132117372630
   PubMed Web of Science ®Google Scholar
• SaartoTWiffenPJAntidepressants for neuropathic pain: a Cochrane reviewJ Neurol Neurosurg Psychiatry201081121372137320543189
   PubMed Web of Science ®Google Scholar
• ArgyriouAABrunaJMarmiroliPCavalettiGChemotherapy-induced peripheral neurotoxicity (CIPN): an updateCrit Rev Oncol Hematol2012821517721908200
   PubMed Web of Science ®Google Scholar
• CavalettiGJakubowiakAJPeripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studiesLeuk Lymphoma20105171178118720497001
   PubMed Web of Science ®Google Scholar
• BrunaJUdinaEAléANeurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in miceExp Neurol2010223259960820188093
   PubMed Web of Science ®Google Scholar
• Ruiz-DurántezETorrecillaMPinedaJUgedoLAttenuation of acute and chronic effects of morphine by the imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline in rat locus coeruleus neuronsBr J Pharmacol2003138349450012569074
   PubMed Web of Science ®Google Scholar
• RaddatzRPariniALanierSMImidazoline/guanidinium binding domains on monoamine oxidases. Relationship to subtypes of imidazoline-binding proteins and tissue-specif ic interaction of imidazoline ligands with monoamine oxidase BJ Biol Chem19952704627961279687499273
   PubMed Web of Science ®Google Scholar
• VegaJAAmentaFHernandezLCdel ValleMEPresence of catecholamine-related enzymes in a subpopulation of primary sensory neurons in dorsal root ganglia of the ratCell Mol Biol19913755195301682049
   PubMed Web of Science ®Google Scholar
• JasminLTienDJanniGOharaPTIs noradrenaline a significant factor in the analgesic effect of antidepressants?Pain20031061–23814581104
   PubMed Web of Science ®Google Scholar
• BannisterKBeeLADickensonAHPreclinical and early clinical investigations related to monoaminergic pain modulationNeurotherapeutics20096470371219789074
   PubMed Web of Science ®Google Scholar
• ThornDAAnXFZhangYPiginiMLiJXCharacterization of the hypothermic effects of imidazoline I(2) receptor agonists in ratsBr J Pharmacol Epub February 10, 2012
   Web of Science ®Google Scholar
• ScholzJWoolfCJThe neuropathic pain triad: neurons, immune cells and gliaNat Neurosci200710111361136817965656
   PubMed Web of Science ®Google Scholar
• KusunoseNKoyanagiSHamamuraKMolecular basis for the dosing time-dependency of anti-allodynic effects of gabapentin in a mouse model of neuropathic painMol Pain201068321108841
   PubMed Web of Science ®Google Scholar
• FlattersSJEffect of analgesic standards on persistent postoperative pain evoked by skin/muscle incision and retraction (SMIR)Neurosci Lett20104771434720417687
   PubMed Web of Science ®Google Scholar